2017-2022 Global and Japan Alexipharmic Drugs Market Analysis Report

Published: Aug, 2017 | Pages: 124 | Publisher: JP Research
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

The global Alexipharmic Drugs market is valued at XX million USD in 2016 and is expected to reach XX million USD by the end of 2017, growing at a CAGR of XX% between 2016 and 2022.

Japan plays an important role in global market, with market size of xx million USD in 2016 and will be xx million USD in 2017, with a CAGR of xx%.

This report, with focus on top players in the global and Japan, studies the Alexipharmic Drugs market's development status and future trend in the global and Japan. It splits Alexipharmic Drugs market by type and by applications to fully and deeply research and reveal market profile and prospect.

The major players include
    ACCORD HLTHCARE
    ACTAVIS ELIZABETH
    AKORN
    ALCON
    ALKERMES
    ALPHARMA PHARMS
    AMNEAL PHARMS
    APOTEX INC
    BARR
    ETHYPHARM USA CORP
    FRESENIUS KABI USA
    GAVIS PHARMS
    HIKMA FARMACEUTICA
    HOPE PHARMS
    HOSPIRA
    KALEO INC
    KREMERS URBAN PHARMS
    MALLINCKRODT
    MERIDIAN MEDCL
    MYLAN LABS LTD
    OREXIGEN
    PFIZER INC
    PROVEPHARM SAS
    SAGENT PHARMS
    SALIX PHARMS
    SANDOZ INC
    SUN PHARM INDS LTD
    TEVA PHARMS USA
    WATSON LABS
    WEST-WARD PHARMS INT

Geographically, this report splits the Global market into the following regions:
    Asia Pacific
        Japan
            Tokyo
            Yokohama
            Osaka
            Nagoya
            Others
        China
        Korea
        India
        Others
    Europe
        France
        Germany
        United Kingdom
        Italy
        Russia
        Others
    North America
        United States
        Canada
    Latin America
        Brazil
        Mexico
        Others
    Southeast Asia
        Singapore
        Malaysia
        Vietnam
        Myanmar
        Thailand
        Indonesia
        Philippines
        Others
    Middle East & Africa
        Saudi Arabia
        Iran
        UAE
        Turkey
        Israel
        Egypt
        South Africa
        Others

On the basis of product, the Alexipharmic Drugs market is primarily split into
Alexipharmic Drugs Market, by Alexipharmic Drugs
    Alexipharmic Drugs
    Tetraethylthiuram Disulfide
    Glutathione
    EDTA
    Penicillamine
    Methylene Blue
    Diethylenetriaminepentaacetic Acid
    2-Aminoethanethiol
    Sodium Nitrite
    Dimercapto Propanol
    Triethylenetetramine
    Na-DMS
    Naloxone
    Naltrexone
    Sodium Thiosulfate
    Pyraloxime
    Pralidoxime Iodide
    Flumazenil

Key Applications
    Internal Medicine
    Medical Emergency
    Hospital
    Pharmacy

 Table of Contents

2017-2022 Global and Japan Alexipharmic Drugs Market Analysis Report
1 Alexipharmic Drugs Overview
    1.1 Product Overview and Scope of Alexipharmic Drugs
    1.2 Global and Japan Alexipharmic Drugs Market by Applications/End Users
        1.2.1 Japan Alexipharmic Drugs Sales () and Market Share Comparison by Applications (2012-2017)
            1.2.1.1 Japan Alexipharmic Drugs Sales () and Market Share by Applications (2012-2017)
            1.2.1.2 Japan Alexipharmic Drugs Sales Growth Rate (%) by Applications (2012-2017)
            1.2.1.3 Market Drivers and Opportunities
        1.2.2 Japan Alexipharmic Drugs Sales () and Market Share Comparison by Applications (2012-2017)
        1.2.3 Global Alexipharmic Drugs Sales by Application (2012-2017)
            1.2.3.1 Global Alexipharmic Drugs Sales () and Market Share by Applications (2012-2017)
            1.2.3.2 Global Alexipharmic Drugs Sales Growth Rate (%) by Applications (2012-2017)
            1.2.3.3 Market Drivers and Opportunities
        1.2.4 Global Alexipharmic Drugs Sales () and Market Share Comparison by Applications (2012-2017)
        1.2.5 Internal Medicine
        1.2.6 Medical Emergency
        1.2.7 Hospital
        1.2.8 Pharmacy
    1.3 Global and Japan Market Size (Sales and Revenue) of Alexipharmic Drugs (2012-2017)
        1.3.1 Japan Market Size (Sales and Revenue) of Alexipharmic Drugs (2012-2017)
            1.3.1.1 Japan Alexipharmic Drugs Sales () and Growth Rate (%) (2012-2017)
            1.3.1.2 Japan Alexipharmic Drugs Revenue (Million USD) and Growth Rate (2012-2017)
        1.3.2 Global Market Size (Sales and Revenue) of Alexipharmic Drugs (2012-2017)
            1.3.2.1 Global Alexipharmic Drugs Sales () and Growth Rate (%) (2012-2017)
            1.3.2.2 Global Alexipharmic Drugs Revenue (Million USD) and Growth Rate (2012-2017)
    1.4 Global and Japan Classification of Alexipharmic Drugs by Alexipharmic Drugs
        1.4.1 Japan Alexipharmic Drugs Sales () and Market Share by Alexipharmic Drugs (2012-2017)
        1.4.2 Global Alexipharmic Drugs Sales () and Market Share by Alexipharmic Drugs (2012-2017)
        1.4.3 Japan Alexipharmic Drugs Revenue (Million USD) and Market Share by Alexipharmic Drugs (2012-2017)
        1.4.4 Global Alexipharmic Drugs Revenue (Million USD) and Market Share by Alexipharmic Drugs (2012-2017)
        1.4.5 Japan Alexipharmic Drugs Price () by Alexipharmic Drugs (2012-2017)
        1.4.6 Global Alexipharmic Drugs Price () by Alexipharmic Drugs (2012-2017)
        1.4.7 Japan Alexipharmic Drugs Sales Growth Rate (%) by Alexipharmic Drugs (2012-2017)
        1.4.8 Global Alexipharmic Drugs Sales Growth Rate (%) by Alexipharmic Drugs (2012-2017)
        1.4.9 Alexipharmic Drugs
        1.4.10 Tetraethylthiuram Disulfide
        1.4.11 Glutathione
        1.4.12 EDTA
        1.4.13 Penicillamine
              Methylene Blue
              Diethylenetriaminepentaacetic Acid
              2-Aminoethanethiol
              Sodium Nitrite
              Dimercapto Propanol
              Triethylenetetramine
              Na-DMS
              Naloxone
              Naltrexone
              Sodium Thiosulfate
              Pyraloxime
              Pralidoxime Iodide
              Flumazenil

2 Global and Japan Alexipharmic Drugs Market Competition by Players/Manufacturers
    2.1 Japan Alexipharmic Drugs Market Competition by Players/Manufacturers
    2.1.1 Japan Alexipharmic Drugs Sales and Market Share of Key Players/Manufacturers (2012-2017)
    2.1.2 Japan Alexipharmic Drugs Revenue and Share by Players/Manufacturers (2012-2017)
    2.1.3 Japan Alexipharmic Drugs Average Price () by Players/Manufacturers (2012-2017)
    2.1.4 Japan Alexipharmic Drugs Market Competitive Situation and Trends
        2.1.4.1 Japan Alexipharmic Drugs Market Concentration Rate
        2.1.4.2 Japan Alexipharmic Drugs Market Share of Top 3 and Top 5 Players/Manufacturers
        2.1.4.3 Mergers & Acquisitions, Expansion in Japan Market
    2.1.5 Japan Players/Manufacturers Alexipharmic Drugs Manufacturing Base Distribution, Sales Area, Product Types
    2.2 Global Alexipharmic Drugs Market Competition by Players/Manufacturers
    2.2.1 Global Alexipharmic Drugs Sales and Market Share of Key Players/Manufacturers (2012-2017)
    2.2.2 Global Alexipharmic Drugs Revenue and Share by Players/Manufacturers (2012-2017)
    2.2.3 Global Alexipharmic Drugs Average Price () by Players/Manufacturers (2012-2017)
    2.2.4 Global Alexipharmic Drugs Market Competitive Situation and Trends
        2.2.4.1 Global Alexipharmic Drugs Market Concentration Rate
        2.2.4.2 Global Alexipharmic Drugs Market Share of Top 3 and Top 5 Players/Manufacturers
        2.2.4.3 Mergers & Acquisitions, Expansion in Global Market
    2.2.5 Global Players/Manufacturers Alexipharmic Drugs Manufacturing Base Distribution, Sales Area, Product Types

3 Global and Japan Alexipharmic Drugs Sales and Revenue by Regions (2012-2017)
    3.1 Asia Pacific Alexipharmic Drugs Sales and Revenue by Regions (2012-2017)
        3.1.1 Japan Alexipharmic Drugs Sales and Revenue  (2012-2017)
            3.1.1.1 Japan Alexipharmic Drugs Sales () and Market Share  (2012-2017)
            3.1.1.2 Japan Alexipharmic Drugs Revenue (Million USD) and Market Share (2012-2017)
            3.1.1.3 Japan Alexipharmic Drugs Price ()(2012-2017)
        3.1.2 China Alexipharmic Drugs Sales and Revenue (2012-2017)
            3.1.2.1 China Alexipharmic Drugs Sales () and Market Share (2012-2017)
            3.1.2.2 China Alexipharmic Drugs Revenue (Million USD) and Market Share (2012-2017)
            3.1.2.3 China Alexipharmic Drugs Price ()(2012-2017)
        3.1.3 Korea Alexipharmic Drugs Sales and Revenue (2012-2017)
            3.1.3.1 Korea Alexipharmic Drugs Sales () and Market Share (2012-2017)
            3.1.3.2 Korea Alexipharmic Drugs Revenue (Million USD) and Market Share (2012-2017)
            3.1.3.3 Korea Alexipharmic Drugs Price ()(2012-2017)
        3.1.4 India Alexipharmic Drugs Sales and Revenue (2012-2017)
            3.1.4.1 India Alexipharmic Drugs Sales () and Market Share (2012-2017)
            3.1.4.2 India Alexipharmic Drugs Revenue (Million USD) and Market Share (2012-2017)
            3.1.4.3 India Alexipharmic Drugs Price ()(2012-2017)
        3.1.5 Others Alexipharmic Drugs Sales and Revenue (2012-2017)
            3.1.5.1 Others Alexipharmic Drugs Sales () and Market Share (2012-2017)
            3.1.5.2 Others Alexipharmic Drugs Revenue (Million USD) and Market Share (2012-2017)
            3.1.5.3 Others Alexipharmic Drugs Price ()(2012-2017)
    3.2 Europe Alexipharmic Drugs Sales and Revenue by Regions (2012-2017)
        3.2.1 France Alexipharmic Drugs Sales and Revenue (2012-2017)
            3.2.1.1 France Alexipharmic Drugs Sales () and Market Share (2012-2017)
            3.2.1.2 France Alexipharmic Drugs Revenue (Million USD) and Market Share (2012-2017)
            3.2.1.3 France Alexipharmic Drugs Price ()(2012-2017)
        3.2.2 Germany Alexipharmic Drugs Sales and Revenue (2012-2017)
            3.2.2.1 Germany Alexipharmic Drugs Sales () and Market Share (2012-2017)
            3.2.2.2 Germany Alexipharmic Drugs Revenue (Million USD) and Market Share (2012-2017)
            3.2.2.3 Germany Alexipharmic Drugs Price ()(2012-2017)
        3.2.3 United Kingdom Alexipharmic Drugs Sales and Revenue (2012-2017)
            3.2.3.1 United Kingdom Alexipharmic Drugs Sales () and Market Share (2012-2017)
            3.2.3.2 United Kingdom Alexipharmic Drugs Revenue (Million USD) and Market Share (2012-2017)
            3.2.3.3 United Kingdom Alexipharmic Drugs Price ()(2012-2017)
        3.2.4 Italy Alexipharmic Drugs Sales and Revenue (2012-2017)
            3.2.4.1 Italy Alexipharmic Drugs Sales () and Market Share (2012-2017)
            3.2.4.2 Italy Alexipharmic Drugs Revenue (Million USD) and Market Share (2012-2017)
            3.2.4.3 Italy Alexipharmic Drugs Price ()(2012-2017)
        3.2.5 Russia Alexipharmic Drugs Sales and Revenue (2012-2017)
            3.2.5.1 Russia Alexipharmic Drugs Sales () and Market Share (2012-2017)
            3.2.5.2 Russia Alexipharmic Drugs Revenue (Million USD) and Market Share (2012-2017)
            3.2.5.3 Russia Alexipharmic Drugs Price ()(2012-2017)
        3.2.6 Others Alexipharmic Drugs Sales and Revenue (2012-2017)
            3.2.6.1 Others Alexipharmic Drugs Sales () and Market Share (2012-2017)
            3.2.6.2 Others Alexipharmic Drugs Revenue (Million USD) and Market Share (2012-2017)
            3.2.6.3 Others Alexipharmic Drugs Price ()(2012-2017)
    3.3 North America Alexipharmic Drugs Sales and Revenue by Regions (2012-2017)
        3.3.1 United States Alexipharmic Drugs Sales and Revenue (2012-2017)
            3.3.1.1 United States Alexipharmic Drugs Sales () and Market Share (2012-2017)
            3.3.1.2 United States Alexipharmic Drugs Revenue (Million USD) and Market Share (2012-2017)
            3.3.1.3 United States Alexipharmic Drugs Price ()(2012-2017)
        3.3.2 Canada Alexipharmic Drugs Sales and Revenue (2012-2017)
            3.3.2.1 Canada Alexipharmic Drugs Sales () and Market Share (2012-2017)
            3.3.2.2 Canada Alexipharmic Drugs Revenue (Million USD) and Market Share (2012-2017)
            3.3.2.3 Canada Alexipharmic Drugs Price ()(2012-2017)
    3.4 Latin America Alexipharmic Drugs Sales and Revenue by Regions (2012-2017)
        3.4.1 Brazil Alexipharmic Drugs Sales and Revenue (2012-2017)
            3.4.1.1 Brazil Alexipharmic Drugs Sales () and Market Share (2012-2017)
            3.4.1.2 Brazil Alexipharmic Drugs Revenue (Million USD) and Market Share (2012-2017)
            3.4.1.3 Brazil Alexipharmic Drugs Price ()(2012-2017)
        3.4.2 Mexico Alexipharmic Drugs Sales and Revenue (2012-2017)
            3.4.2.1 Mexico Alexipharmic Drugs Sales () and Market Share (2012-2017)
            3.4.2.2 Mexico Alexipharmic Drugs Revenue (Million USD) and Market Share (2012-2017)
            3.4.2.3 Mexico Alexipharmic Drugs Price ()(2012-2017)
        3.4.3 Others Alexipharmic Drugs Sales and Revenue (2012-2017)
            3.4.3.1 Others Alexipharmic Drugs Sales () and Market Share (2012-2017)
            3.4.3.2 Others Alexipharmic Drugs Revenue (Million USD) and Market Share (2012-2017)
            3.4.3.3 Others Alexipharmic Drugs Price ()(2012-2017)
    3.5 Southeast Asia Alexipharmic Drugs Sales and Revenue by Regions (2012-2017)
        3.5.1 Singapore Alexipharmic Drugs Sales and Revenue (2012-2017)
            3.5.1.1 Singapore Alexipharmic Drugs Sales () and Market Share (2012-2017)
            3.5.1.2 Singapore Alexipharmic Drugs Revenue (Million USD) and Market Share (2012-2017)
            3.5.1.3 Singapore Alexipharmic Drugs Price ()(2012-2017)
        3.5.2 Malaysia Alexipharmic Drugs Sales and Revenue (2012-2017)
            3.5.2.1 Malaysia Alexipharmic Drugs Sales () and Market Share (2012-2017)
            3.5.2.2 Malaysia Alexipharmic Drugs Revenue (Million USD) and Market Share (2012-2017)
            3.5.2.3 Malaysia Alexipharmic Drugs Price ()(2012-2017)
        3.5.3 Vietnam Alexipharmic Drugs Sales and Revenue (2012-2017)
            3.5.3.1 Vietnam Alexipharmic Drugs Sales () and Market Share (2012-2017)
            3.5.3.2 Vietnam Alexipharmic Drugs Revenue (Million USD) and Market Share (2012-2017)
            3.5.3.3 Vietnam Alexipharmic Drugs Price ()(2012-2017)
        3.5.4 Myanmar Alexipharmic Drugs Sales and Revenue (2012-2017)
            3.5.4.1 Myanmar Alexipharmic Drugs Sales () and Market Share (2012-2017)
            3.5.4.2 Myanmar Alexipharmic Drugs Revenue (Million USD) and Market Share (2012-2017)
            3.5.4.3 Myanmar Alexipharmic Drugs Price ()(2012-2017)
        3.5.5 Thailand Alexipharmic Drugs Sales and Revenue (2012-2017)
            3.5.5.1 Thailand Alexipharmic Drugs Sales () and Market Share (2012-2017)
            3.5.5.2 Thailand Alexipharmic Drugs Revenue (Million USD) and Market Share (2012-2017)
            3.5.5.3 Thailand Alexipharmic Drugs Price ()(2012-2017)
        3.5.6 Indonesia Alexipharmic Drugs Sales and Revenue (2012-2017)
            3.5.6.1 Indonesia Alexipharmic Drugs Sales () and Market Share (2012-2017)
            3.5.6.2 Indonesia Alexipharmic Drugs Revenue (Million USD) and Market Share (2012-2017)
            3.5.6.3 Indonesia Alexipharmic Drugs Price ()(2012-2017)
        3.5.7 Philippines Alexipharmic Drugs Sales and Revenue (2012-2017)
            3.5.7.1 Philippines Alexipharmic Drugs Sales () and Market Share (2012-2017)
            3.5.7.2 Philippines Alexipharmic Drugs Revenue (Million USD) and Market Share (2012-2017)
            3.5.7.3 Philippines Alexipharmic Drugs Price ()(2012-2017)
        3.5.8 Others Alexipharmic Drugs Sales and Revenue (2012-2017)
            3.5.8.1 Others Alexipharmic Drugs Sales () and Market Share (2012-2017)
            3.5.8.2 Others Alexipharmic Drugs Revenue (Million USD) and Market Share (2012-2017)
            3.5.8.3 Others Alexipharmic Drugs Price ()(2012-2017)
    3.6 Middle East & Africa Alexipharmic Drugs Sales and Revenue by Regions (2012-2017)
        3.6.1 Saudi Arabia Alexipharmic Drugs Sales and Revenue (2012-2017)
            3.6.1.1 Saudi Arabia Alexipharmic Drugs Sales () and Market Share (2012-2017)
            3.6.1.2 Saudi Arabia Alexipharmic Drugs Revenue (Million USD) and Market Share (2012-2017)
            3.6.1.3 Saudi Arabia Alexipharmic Drugs Price ()(2012-2017)
        3.6.2 Iran Alexipharmic Drugs Sales and Revenue (2012-2017)
            3.6.2.1 Iran Alexipharmic Drugs Sales () and Market Share (2012-2017)
            3.6.2.2 Iran Alexipharmic Drugs Revenue (Million USD) and Market Share (2012-2017)
            3.6.2.3 Iran Alexipharmic Drugs Price ()(2012-2017)
        3.6.3 UAE Alexipharmic Drugs Sales and Revenue (2012-2017)
            3.6.3.1 UAE Alexipharmic Drugs Sales () and Market Share (2012-2017)
            3.6.3.2 UAE Alexipharmic Drugs Revenue (Million USD) and Market Share (2012-2017)
            3.6.3.3 UAE Alexipharmic Drugs Price ()(2012-2017)
        3.6.4 Turkey Alexipharmic Drugs Sales and Revenue (2012-2017)
            3.6.4.1 Turkey Alexipharmic Drugs Sales () and Market Share (2012-2017)
            3.6.4.2 Turkey Alexipharmic Drugs Revenue (Million USD) and Market Share (2012-2017)
            3.6.4.3 Turkey Alexipharmic Drugs Price ()(2012-2017)
        3.6.5 Israel Alexipharmic Drugs Sales and Revenue (2012-2017)
            3.6.5.1 Israel Alexipharmic Drugs Sales () and Market Share (2012-2017)
            3.6.5.2 Israel Alexipharmic Drugs Revenue (Million USD) and Market Share (2012-2017)
            3.6.5.3 Israel Alexipharmic Drugs Price ()(2012-2017)
        3.6.6 Egypt Alexipharmic Drugs Sales and Revenue (2012-2017)
            3.6.6.1 Egypt Alexipharmic Drugs Sales () and Market Share (2012-2017)
            3.6.6.2 Egypt Alexipharmic Drugs Revenue (Million USD) and Market Share (2012-2017)
            3.6.6.3 Egypt Alexipharmic Drugs Price ()(2012-2017)
        3.6.7 South Africa Alexipharmic Drugs Sales and Revenue (2012-2017)
            3.6.7.1 South Africa Alexipharmic Drugs Sales () and Market Share (2012-2017)
            3.6.7.2 South Africa Alexipharmic Drugs Revenue (Million USD) and Market Share (2012-2017)
            3.6.7.3 South Africa Alexipharmic Drugs Price ()(2012-2017)
        3.6.8 Others Alexipharmic Drugs Sales and Revenue (2012-2017)
            3.6.8.1 Others Alexipharmic Drugs Sales () and Market Share (2012-2017)
            3.6.8.2 Others Alexipharmic Drugs Revenue (Million USD) and Market Share (2012-2017)
            3.6.8.3 Others Alexipharmic Drugs Price ()(2012-2017)

4 Global and Japan Alexipharmic Drugs Players/Manufacturers Profiles and Sales Data
    4.1 ACCORD HLTHCARE
        4.1.1 Company Basic Information, Manufacturing Base and Competitors
        4.1.2 Alexipharmic Drugs Product Category, Application and Specification
            4.1.2.1 Product A
            4.1.2.2 Product B
        4.1.3 ACCORD HLTHCARE Alexipharmic Drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
        4.1.4 Main Business/Business Overview
    4.2 ACTAVIS ELIZABETH
        4.2.1 Company Basic Information, Manufacturing Base and Competitors
        4.2.2 Alexipharmic Drugs Product Category, Application and Specification
            4.2.2.1 Product A
            4.2.2.2 Product B
        4.2.3 ACTAVIS ELIZABETH Alexipharmic Drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
        4.2.4 Main Business/Business Overview
    4.3 AKORN
        4.3.1 Company Basic Information, Manufacturing Base and Competitors
        4.3.2 Alexipharmic Drugs Product Category, Application and Specification
            4.3.2.1 Product A
            4.3.2.2 Product B
        4.3.3 AKORN Alexipharmic Drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
        4.3.4 Main Business/Business Overview
    4.4 ALCON
        4.4.1 Company Basic Information, Manufacturing Base and Competitors
        4.4.2 Alexipharmic Drugs Product Category, Application and Specification
            4.4.2.1 Product A
            4.4.2.2 Product B
        4.4.3 ALCON Alexipharmic Drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
        4.4.4 Main Business/Business Overview
    4.5 ALKERMES
        4.5.1 Company Basic Information, Manufacturing Base and Competitors
        4.5.2 Alexipharmic Drugs Product Category, Application and Specification
            4.5.2.1 Product A
            4.5.2.2 Product B
        4.5.3 ALKERMES Alexipharmic Drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
        4.5.4 Main Business/Business Overview
    4.6 ALPHARMA PHARMS
        4.6.1 Company Basic Information, Manufacturing Base and Competitors
        4.6.2 Alexipharmic Drugs Product Category, Application and Specification
            4.6.2.1 Product A
            4.6.2.2 Product B
        4.6.3 ALPHARMA PHARMS Alexipharmic Drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
        4.6.4 Main Business/Business Overview
    4.7 AMNEAL PHARMS
        4.7.1 Company Basic Information, Manufacturing Base and Competitors
        4.7.2 Alexipharmic Drugs Product Category, Application and Specification
            4.7.2.1 Product A
            4.7.2.2 Product B
        4.7.3 AMNEAL PHARMS Alexipharmic Drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
        4.7.4 Main Business/Business Overview
    4.8 APOTEX INC
        4.8.1 Company Basic Information, Manufacturing Base and Competitors
        4.8.2 Alexipharmic Drugs Product Category, Application and Specification
            4.8.2.1 Product A
            4.8.2.2 Product B
        4.8.3 APOTEX INC Alexipharmic Drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
        4.8.4 Main Business/Business Overview
    4.9 BARR
        4.9.1 Company Basic Information, Manufacturing Base and Competitors
        4.9.2 Alexipharmic Drugs Product Category, Application and Specification
            4.9.2.1 Product A
            4.9.2.2 Product B
        4.9.3 BARR Alexipharmic Drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
        4.9.4 Main Business/Business Overview
    4.10 ETHYPHARM USA CORP
        4.10.1 Company Basic Information, Manufacturing Base and Competitors
        4.10.2 Alexipharmic Drugs Product Category, Application and Specification
            4.10.2.1 Product A
            4.10.2.2 Product B
        4.10.3 ETHYPHARM USA CORP Alexipharmic Drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
        4.10.4 Main Business/Business Overview
    4.11 FRESENIUS KABI USA
    4.12 GAVIS PHARMS
    4.13 HIKMA FARMACEUTICA
    4.14 HOPE PHARMS
    4.15 HOSPIRA
    4.16 KALEO INC
    4.17 KREMERS URBAN PHARMS
    4.18 MALLINCKRODT
    4.19 MERIDIAN MEDCL
    4.20 MYLAN LABS LTD
    4.21 OREXIGEN
    4.22 PFIZER INC
    4.23 PROVEPHARM SAS
    4.24 SAGENT PHARMS
    4.25 SALIX PHARMS
    4.26 SANDOZ INC
    4.27 SUN PHARM INDS LTD
    4.28 TEVA PHARMS USA
    4.29 WATSON LABS
    4.30 WEST-WARD PHARMS INT

5 Alexipharmic Drugs Manufacturing Cost Analysis
    5.1 Alexipharmic Drugs Key Raw Materials Analysis
        5.1.1 Key Raw Materials
        5.1.2 Price Trend of Key Raw Materials
        5.1.3 Key Suppliers of Raw Materials
        5.1.4 Market Concentration Rate of Raw Materials
    5.2 Proportion of Manufacturing Cost Structure
        5.2.1 Raw Materials
        5.2.2 Labor Cost
        5.2.3 Manufacturing Expenses
    5.3 Manufacturing Process Analysis of Alexipharmic Drugs

6 Industrial Chain, Sourcing Strategy and Downstream Buyers
    6.1 Alexipharmic Drugs Industrial Chain Analysis
    6.2 Upstream Raw Materials Sourcing
    6.3 Raw Materials Sources of Alexipharmic Drugs Major Players/Manufacturers in 2016
    6.4 Downstream Buyers

7 Marketing Strategy Analysis, Distributors/Traders
    7.1 Marketing Channel
        7.1.1 Direct Marketing
        7.1.2 Indirect Marketing
        7.1.3 Marketing Channel Development Trend
    7.2 Market Positioning
        7.2.1 Pricing Strategy
        7.2.2 Brand Strategy
        7.2.3 Target Client
    7.3 Distributors/Traders List

8 Market Effect Factors Analysis
    8.1 Technology Progress/Risk
        8.1.1 Substitutes Threat
        8.1.2 Technology Progress in Related Industry
    8.2 Consumer Needs/Customer Preference Change
    8.3 Economic/Political Environmental Change

9 Global and Japan Alexipharmic Drugs Market Size (Sales and Revenue) Forecast (2017-2022)
    9.1 Global and Japan Alexipharmic Drugs Sales (), Revenue (Million USD) Forecast (2017-2022)
    9.2 Global and Japan Alexipharmic Drugs Sales () Forecast by Type (2017-2022)
        9.2.1 by Alexipharmic Drugs
        9.2.2 by 
    9.3 Global and Japan Alexipharmic Drugs Sales () Forecast by Application (2017-2022)
    9.4 Global and Japan Alexipharmic Drugs Sales () Forecast by Regions (2017-2022)

10 Research Findings and Conclusion

11 Methodology and Data Source
    11.1 Methodology/Research Approach
        11.1.1 Research Programs/Design
        11.1.2 Market Size Estimation
        11.1.3 Market Breakdown and Data Triangulation
    11.2 Data Source
        11.2.1 Secondary Sources
        11.2.2 Primary Sources
    11.3 Disclaimer
    11.4 Author List

List of Tables and Figures

    Figure Product Picture of Alexipharmic Drugs
    Table Japan Alexipharmic Drugs Sales (Million Units) Comparison by Applications (2012-2017)
    Figure Japan Sales Market Share (%) of Alexipharmic Drugs by Applications in 2016
    Table Global Alexipharmic Drugs Sales (Million Units) Comparison by Applications (2012-2017)
    Figure Global Sales Market Share (%) of Alexipharmic Drugs by Applications in 2016
    Figure Internal Medicine Examples
    Table Key Downstream Customer in Internal Medicine
    Figure Medical Emergency Examples
    Table Key Downstream Customer in Medical Emergency
    Figure Hospital Examples
    Table Key Downstream Customer in Hospital
    Figure Pharmacy Examples
    Table Key Downstream Customer in Pharmacy
    Figure Alexipharmic Drugs Product Picture
    Figure Tetraethylthiuram Disulfide Product Picture
    Figure Glutathione Product Picture
    Figure EDTA Product Picture
    Figure Penicillamine Product Picture
    Figure  Product Picture
    Figure  Product Picture
    Table ACCORD HLTHCARE Basic Information List
    Table ACCORD HLTHCARE Alexipharmic Drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
    Table ACCORD HLTHCARE Alexipharmic Drugs Sales Growth Rate (%)(2012-2017)
    Table ACCORD HLTHCARE Alexipharmic Drugs Sales Market Share (%) in Japan (2012-2017)
    Figure ACCORD HLTHCARE Alexipharmic Drugs Revenue Market Share (%) in Japan (2012-2017)
    Table ACTAVIS ELIZABETH Basic Information List
    Table ACTAVIS ELIZABETH Alexipharmic Drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
    Table ACTAVIS ELIZABETH Alexipharmic Drugs Sales Growth Rate (%)(2012-2017)
    Table ACTAVIS ELIZABETH Alexipharmic Drugs Sales Market Share (%) in Japan (2012-2017)
    Figure ACTAVIS ELIZABETH Alexipharmic Drugs Revenue Market Share (%) in Japan (2012-2017)
    Table AKORN Basic Information List
    Table AKORN Alexipharmic Drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
    Table AKORN Alexipharmic Drugs Sales Growth Rate (%)(2012-2017)
    Table AKORN Alexipharmic Drugs Sales Market Share (%) in Japan (2012-2017)
    Figure AKORN Alexipharmic Drugs Revenue Market Share (%) in Japan (2012-2017)
    Table ALCON Basic Information List
    Table ALCON Alexipharmic Drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
    Table ALCON Alexipharmic Drugs Sales Growth Rate (%)(2012-2017)
    Table ALCON Alexipharmic Drugs Sales Market Share (%) in Japan (2012-2017)
    Figure ALCON Alexipharmic Drugs Revenue Market Share (%) in Japan (2012-2017)
    Table ALKERMES Basic Information List
    Table ALKERMES Alexipharmic Drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
    Table ALKERMES Alexipharmic Drugs Sales Growth Rate (%)(2012-2017)
    Table ALKERMES Alexipharmic Drugs Sales Market Share (%) in Japan (2012-2017)
    Figure ALKERMES Alexipharmic Drugs Revenue Market Share (%) in Japan (2012-2017)
    Table ALPHARMA PHARMS Basic Information List
    Table ALPHARMA PHARMS Alexipharmic Drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
    Table ALPHARMA PHARMS Alexipharmic Drugs Sales Growth Rate (%)(2012-2017)
    Table ALPHARMA PHARMS Alexipharmic Drugs Sales Market Share (%) in Japan (2012-2017)
    Figure ALPHARMA PHARMS Alexipharmic Drugs Revenue Market Share (%) in Japan (2012-2017)
    Table AMNEAL PHARMS Basic Information List
    Table AMNEAL PHARMS Alexipharmic Drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
    Table AMNEAL PHARMS Alexipharmic Drugs Sales Growth Rate (%)(2012-2017)
    Table AMNEAL PHARMS Alexipharmic Drugs Sales Market Share (%) in Japan (2012-2017)
    Figure AMNEAL PHARMS Alexipharmic Drugs Revenue Market Share (%) in Japan (2012-2017)
    Table APOTEX INC Basic Information List
    Table APOTEX INC Alexipharmic Drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
    Table APOTEX INC Alexipharmic Drugs Sales Growth Rate (%)(2012-2017)
    Table APOTEX INC Alexipharmic Drugs Sales Market Share (%) in Japan (2012-2017)
    Figure APOTEX INC Alexipharmic Drugs Revenue Market Share (%) in Japan (2012-2017)
    Table BARR Basic Information List
    Table BARR Alexipharmic Drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
    Table BARR Alexipharmic Drugs Sales Growth Rate (%)(2012-2017)
    Table BARR Alexipharmic Drugs Sales Market Share (%) in Japan (2012-2017)
    Figure BARR Alexipharmic Drugs Revenue Market Share (%) in Japan (2012-2017)
    Table ETHYPHARM USA CORP Basic Information List
    Table ETHYPHARM USA CORP Alexipharmic Drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
    Table ETHYPHARM USA CORP Alexipharmic Drugs Sales Growth Rate (%)(2012-2017)
    Table ETHYPHARM USA CORP Alexipharmic Drugs Sales Market Share (%) in Japan (2012-2017)
    Figure ETHYPHARM USA CORP Alexipharmic Drugs Revenue Market Share (%) in Japan (2012-2017)
    Table FRESENIUS KABI USA Basic Information List
    Table GAVIS PHARMS Basic Information List
    Table HIKMA FARMACEUTICA Basic Information List
    Table HOPE PHARMS Basic Information List
    Table HOSPIRA Basic Information List
    Table KALEO INC Basic Information List
    Table KREMERS URBAN PHARMS Basic Information List
    Table MALLINCKRODT Basic Information List
    Table MERIDIAN MEDCL Basic Information List
    Table MYLAN LABS LTD Basic Information List
    Table OREXIGEN Basic Information List
    Table PFIZER INC Basic Information List
    Table PROVEPHARM SAS Basic Information List
    Table SAGENT PHARMS Basic Information List
    Table SALIX PHARMS Basic Information List
    Table SANDOZ INC Basic Information List
    Table SUN PHARM INDS LTD Basic Information List
    Table TEVA PHARMS USA Basic Information List
    Table WATSON LABS Basic Information List
    Table WEST-WARD PHARMS INT Basic Information List
    Table Production Base and Market Concentration Rate of Raw Material
    Figure Price Trend of Key Raw Materials
    Table Key Suppliers of Raw Materials
    Figure Manufacturing Cost Structure of Alexipharmic Drugs
    Figure Manufacturing Process Analysis of Alexipharmic Drugs
    Figure Alexipharmic Drugs Industrial Chain Analysis
    Table Raw Materials Sources of Alexipharmic Drugs Major Players/Manufacturers in 2016
    Table Major Buyers of Alexipharmic Drugs
    Table Distributors/Traders List
    Figure Japan Alexipharmic Drugs Sales () and Growth Rate (%) Forecast (2017-2022)
    Figure Japan Alexipharmic Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
    Figure Japan Alexipharmic Drugs Price () Trend Forecast (2017-2022)
    Figure Global Alexipharmic Drugs Sales () and Growth Rate (%) Forecast (2017-2022)
    Figure Global Alexipharmic Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
    Figure Global Alexipharmic Drugs Price () Trend Forecast (2017-2022)
    Table Japan Alexipharmic Drugs Sales () Forecast by Type (2017-2022)
    Table Global Alexipharmic Drugs Sales () Forecast by Type (2017-2022)
    Figure Japan Alexipharmic Drugs Sales () Forecast by Type (2017-2022)
    Figure Global Alexipharmic Drugs Sales () Forecast by Type (2017-2022)
    Figure Japan Alexipharmic Drugs Sales Volume Market Share Forecast by Type in 2017
    Figure Global Alexipharmic Drugs Sales Volume Market Share Forecast by Type in 2017
    Table Japan Alexipharmic Drugs Sales () Forecast by Application (2017-2022)
    Figure Japan Alexipharmic Drugs Sales Volume Market Share Forecast by Application (2017-2022)
    Figure Japan Alexipharmic Drugs Sales Volume Market Share Forecast by Application in 2017
    Table Global Alexipharmic Drugs Sales () Forecast by Application (2017-2022)
    Figure Global Alexipharmic Drugs Sales Volume Market Share Forecast by Application (2017-2022)
    Figure Global Alexipharmic Drugs Sales Volume Market Share Forecast by Application in 2017
    Table Japan Alexipharmic Drugs Sales () Forecast by Regions (2017-2022)
    Table Japan Alexipharmic Drugs Sales Volume Share Forecast by Regions (2017-2022)
    Figure Japan Alexipharmic Drugs Sales Volume Share Forecast by Regions (2017-2022)
    Table Global Alexipharmic Drugs Sales () Forecast by Regions (2017-2022)
    Table Global Alexipharmic Drugs Sales Volume Share Forecast by Regions (2017-2022)
    Figure Global Alexipharmic Drugs Sales Volume Share Forecast by Regions (2017-2022)
    Table Research Programs/Design for This Report
    Figure Bottom-up and Top-down Approaches for This Report
    Figure Data Triangulation
    Table Key Data Information from Secondary Sources
    Table Key Data Information from Primary Sources